|
Personal data - diagnosis
|
Personal data
| Visible name: |
timebender |
| Ctry: |
Deutschland |
| State/Province: |
Brandenburg |
| Year of birth: |
1947 |
| Age: |
77 |
| Occupation: |
Informatiker, Rentner |
| Hobbies: |
Fotografie, Literatur, Philosophie |
| My Website: |
|
|
Data at initial diagnosis
| Date: |
10.10.2001 |
| Age at diagnosis: |
54 |
| PSA: |
7.50 |
| Biopsied? |
Yes |
| TUR-P? |
No |
| Gleason Score: |
2 + 3 = 5 |
| TNM-Stages: |
pT2b N0 M0 |
| Remark: |
09/2001 bei klin. Prostatitis PSA 14 |
|
|
Maximum measured prostate volume
| Date: |
29.10.2001 |
| PSA: |
7.50 |
| Volume in ml or cm³: |
22 ml |
|
Postoperative pathological data
| Date: |
02.11.2001 |
| Gleason Score: |
2 + 3 = 5 |
| pTNM-classification: |
pT 2b pN 0 M0 |
| Margins: |
R0 |
| p-L-V-P-G-Findings: |
G IIa |
| See stories of: |
14.11.2001 |
|
|
Prostate cancer treatments
** PSA level at the start of the treatment
|
| from |
to |
PSA** |
Type |
Clinic |
City |
|
29.10.01 |
15.11.01 |
7.50 |
Open surgery |
Franziskus-Krankenhaus |
Berlin |
|
20.01.05 |
23.03.05 |
0.26 |
IMRT |
Charité Benjamin Franklin |
Berlin |
|
25.01.12 |
|
5.80 |
ADT1 |
|
Berlin |
|
08.02.12 |
04.08.12 |
0.17 |
ADT2 |
|
Berlin |
|
04.08.12 |
02.11.12 |
1.10 |
ADT3 |
|
Berlin |
|
02.11.12 |
10.12.12 |
1.10 |
ADT1 |
|
Berlin |
|
11.12.12 |
|
1.10 |
ADT2 |
|
Berlin |
|
05.05.14 |
|
1.61 |
other ADT |
|
Berlin |
|
16.11.15 |
11.12.15 |
3.21 |
IMRT |
Helios Klinikum |
Berlin-Buch |
|
10.05.17 |
12.08.17 |
3.40 |
ADT1 |
|
|
|
13.10.17 |
|
6.73 |
other ADT |
|
|
|
|
Drugs
NEM = Nutritional supplement
|
| from |
to |
Medication |
Quantity / unit of time |
|
25.01.12 |
08.02.12 |
Bicalutamid |
50mg/T |
|
08.02.12 |
05.05.14 |
Leuprone |
1 Spritze/Quartal |
|
05.05.14 |
|
Profact |
1 Spritze/Quartal |
|
30.04.15 |
|
Leuprone |
1 Spritze/Quartal |
|
01.05.15 |
17.09.15 |
Enzalutamid (Xtandi) |
4 Kapseln/d |
|
10.05.17 |
12.08.17 |
Bicalutamid 150mg |
1-0-0 |
|
26.09.17 |
20.10.17 |
Bicalutamid 50mg |
1-0-0 |
|
20.10.17 |
05.01.18 |
Depot-Spritze |
|
Quantity per D / M / Y etc.
|
